Genex Pharmaceutical Inc. (GENX)
OTC PINK OTC PINK Primary Summary
GENX Chart
Genex Pharmaceutical Inc. (GENX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Genex Pharmaceutical Inc. ever had a stock split?
Genex Pharmaceutical Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Fuzhi Song CEO | OTC PINK Exchange | 37227T105 CUSIP |
| CN Country | 86 Employees | - Last Dividend | 1 Jul 2004 Last Split | - IPO Date |
Overview
Genex Pharmaceutical, Inc. is a pioneering medical device manufacturer based in Tianjin City, within the People's Republic of China. The company specializes in the production and distribution of a unique medical device known as Reconstituted Bone Xenograft (RBX), primarily within the Chinese market. RBX is acclaimed for its capabilities in accelerating the process of bone healing, making it a valuable asset in the medical field. Genex Pharmaceutical boasts a wide distribution network, encompassing approximately 500 hospitals across China, in addition to other medical device entities. This extensive distribution network underscores the company's significant role in China's healthcare sector, particularly in the domain of orthopedic and bone healing solutions.
Products and Services
- Reconstituted Bone Xenograft (RBX)
At the heart of Genex Pharmaceutical's product lineup is the Reconstituted Bone Xenograft (RBX). This innovative medical device is designed to aid in the acceleration of bone healing processes. Utilizing xenograft technology, RBX serves as an essential tool for orthopedic surgeons and patients requiring bone repair and regeneration. Its deployment across numerous hospitals testifies to its effectiveness and high demand within the medical community. Genex Pharmaceutical's commitment to improving orthopedic health care is vividly illustrated through its continuous research and development in RBX technology.
